Stocks Above the 200-Day Moving Average — Performance View · Electromedical & Electrotherapeutic Apparatus
11 stocks match the Stocks Above the 200-Day Moving Average screen. Stocks trading above their 200-day moving average — a long-term uptrend filter, largest first. Performance columns. Filtered to Electromedical & Electrotherapeutic Apparatus. Data as of close · Checked
| MDT | Medtronic | +10.80% | +20.61% | +22.25% | +35.39% | +16.45% | +9.33% | 2.7% | 2.5% | 0.83 | 845K | 105.04 | +6.22% | 697K |
| LIVN | Livanova Plc | +16.78% | +25.76% | +24.32% | +42.28% | +79.36% | +53.10% | 4.4% | 3.2% | 8.29 | 55K | 94.22 | +17.67% | 460K |
| ITGR | Integer Holdings Corp | +0.07% | +0.12% | +0.54% | +46.77% | +89.39% | +61.39% | 0.1% | 0.1% | 1.00 | 40K | 126.64 | +0.02% | 40K |
| AXGN | Axogen, Inc. | +4.30% | +41.35% | +15.71% | +18.08% | +120.56% | +56.84% | 3.7% | 4.0% | 1.73 | 92K | 51.33 | +3.67% | 159K |
| CNMD | Conmed Corp | +17.69% | +20.72% | +7.89% | +43.90% | +19.76% | +32.23% | 5.7% | 4.7% | 1.91 | 21K | 53.69 | +13.41% | 40K |
| CBLL | Ceribell, Inc. | +0.33% | +12.11% | +49.81% | +35.47% | +140.83% | +24.48% | 7.5% | 5.5% | 3.59 | 27K | 27.31 | -3.50% | 96K |
| CV | CapsoVision, Inc | -2.62% | +6.09% | -0.51% | -3.16% | +44.04% | -36.60% | 4.2% | 3.6% | 1.12 | 9K | 6.88 | +2.91% | 10K |
| NRXS | Neuraxis, INC | -10.01% | +0.37% | -1.01% | -22.74% | +149.27% | +51.44% | 3.5% | 4.4% | 0.21 | 3K | 6.83 | +2.94% | 611 |
| OM | Outset Medical, Inc. | +2.53% | +7.23% | -14.18% | -1.11% | -65.81% | +19.62% | 4.9% | 5.3% | 0.32 | 6K | 4.45 | +9.34% | 2K |
| ECOR | electroCore, Inc. | +1.75% | -16.19% | +20.14% | +25.52% | +65.23% | +88.99% | 6.5% | 5.2% | 1.22 | 2K | 8.41 | +17.95% | 2K |
| POCI | PRECISION OPTICS CORPORATION, INC. | +10.14% | +6.73% | +14.03% | +2.65% | +3.76% | +16.23% | 2.9% | 2.0% | 0.14 | 846 | 4.83 | +1.36% | 120 |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.